8 Results for "

myotoxicity

" in MedChemExpress (MCE) Product Catalog:
Products (8)

8 Results for "myotoxicity" in MCE Product Catalog:

2
2 Cited Publications
Cat. No.: HY-14925
CAS No.: 189059-71-0
Purity:  99.81%
Synonyms: T-91485
Lapaquistat (T-91485), a cholesterol biosynthesis inhibitor, is the active metabolite of Lapaquistat acetate (HY-16274). Lapaquistat can decrease statin-induced myotoxicity in lipid-lowering therapy .
loading...
    loading...
Cat. No.: HY-101873
CAS No.: 125995-03-1
Purity:  96.95%
Atorvastatin lactone is a metabolite of Atorvastatin acid, an HMG-CoA reductase inhibitor. Atorvastatin lactone exhibits myotoxicity .
loading...
    loading...
Cat. No.: HY-D1005A25
CAS No.: 9003-11-6
Synonyms: PEG-PPG-PEG, 5750 (Average)
Poloxamer 403 P123 is a block copolymer of polyoxyethylene and polyoxypropylene with an average molecular weight of 5750. Poloxamer has the ability to inhibit P-gp. Poloxamer 403 increases creatine kinase levels. Poloxamer 403 is myotoxic .
loading...
    loading...
Cat. No.: HY-120078
CAS No.: 1845753-81-2
Target:  

Phospholipase

Research Areas:  

Cardiovascular Disease

AZD2716 is an orally active secretory phospholipase A2 (sPLA2) inhibitor. AZD2716 inhibits human GIIA sPLA2 (IC50=10 nM), human GV sPLA2 (IC50=40 nM), human GX sPLA2 (IC50=400 nM), snake venom sPLA2 (IC50=2 pM), and snake (Bothrops jararacussu) Lys49-PLA2-like toxin (Kd=110 μM). AZD2716 inhibits sPLA2 isoforms IIa, V, X, snake venom sPLA2s, and snake venom Lys49-PLA2-like toxin myotoxic activity via hydrophobic channel binding. AZD2716 suppresses GIIA sPLA2 production, neutralizes snake venom-induced myotoxicity, and improves survival in envenomed mice. AZD2716 can be used for the research of coronary artery disease, atherosclerosis, and snakebite envenoming .
loading...
    loading...
Cat. No.: HY-101873S
Atorvastatin lactone-d5 is the d5-labeled Atorvastatin lactone (HY-101873). Atorvastatin lactone is a metabolite of Atorvastatin acid, an HMG-CoA reductase inhibitor. Atorvastatin lactone exhibits myotoxicity .
loading...
    loading...
Cat. No.: HY-137213
CAS No.: 94061-83-3
Research Areas:  

Inflammation/Immunology

Fluvastatin lactone is the lactone form of Fluvastatin (HY-14664) detected in human plasma after administration. It competitively or mixed-type inhibits CYP2C9-catalyzed S-Warfarin 7-hydroxylation, and induces myotoxicity in a concentration- and time-dependent manner in rat and primary human skeletal muscle cells, reducing the number of surviving myotubes and causing morphological changes in myotubes. Fluvastatin lactone can be used for studies on myotoxicity and statin-induced myotoxicity .
loading...
    loading...
Cat. No.: HY-101873R
CAS No.: 125995-03-1
Atorvastatin lactone (Standard) is the analytical standard of Atorvastatin lactone (HY-101873). This product is intended for research and analytical applications. Atorvastatin lactone is a metabolite of Atorvastatin acid, an HMG-CoA reductase inhibitor. Atorvastatin lactone exhibits myotoxicity .
loading...
    loading...
Cat. No.: HY-16108
CAS No.: 157126-18-6
BMS-187745 is a squalene synthase inhibitor. BMS-187745 reduces cholesterol synthesis. BMS-187745 does not induce significant myotoxicity in skeletal muscle .
loading...
    loading...